Goldman Sachs’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.7M Sell
579,392
-511,263
-47% -$3.26M ﹤0.01% 3025
2025
Q1
$5.3M Buy
1,090,655
+121,583
+13% +$591K ﹤0.01% 2697
2024
Q4
$9.26M Buy
969,072
+521,224
+116% +$4.98M ﹤0.01% 2391
2024
Q3
$3.74M Sell
447,848
-163,121
-27% -$1.36M ﹤0.01% 2965
2024
Q2
$4.17M Buy
610,969
+318,016
+109% +$2.17M ﹤0.01% 2743
2024
Q1
$741K Sell
292,953
-458,934
-61% -$1.16M ﹤0.01% 3784
2023
Q4
$1.8M Buy
751,887
+93,301
+14% +$224K ﹤0.01% 3278
2023
Q3
$2.24M Sell
658,586
-11,864
-2% -$40.3K ﹤0.01% 3025
2023
Q2
$4.93M Sell
670,450
-230,095
-26% -$1.69M ﹤0.01% 2580
2023
Q1
$9.33M Buy
900,545
+120,900
+16% +$1.25M ﹤0.01% 2064
2022
Q4
$9.21M Buy
779,645
+320,923
+70% +$3.79M ﹤0.01% 2191
2022
Q3
$9.63M Buy
458,722
+387
+0.1% +$8.12K ﹤0.01% 2156
2022
Q2
$14.2M Buy
458,335
+109,018
+31% +$3.38M ﹤0.01% 1857
2022
Q1
$14.3M Buy
349,317
+33,632
+11% +$1.38M ﹤0.01% 1952
2021
Q4
$13.7M Sell
315,685
-391,936
-55% -$17M ﹤0.01% 2033
2021
Q3
$35.4M Buy
707,621
+52,521
+8% +$2.63M 0.01% 1321
2021
Q2
$41.3M Buy
655,100
+176,729
+37% +$11.1M 0.01% 1218
2021
Q1
$44.4M Sell
478,371
-422,244
-47% -$39.2M 0.01% 1109
2020
Q4
$80.7M Buy
900,615
+257,334
+40% +$23.1M 0.02% 641
2020
Q3
$66.5M Sell
643,281
-119,943
-16% -$12.4M 0.02% 705
2020
Q2
$60.4M Sell
763,224
-202,716
-21% -$16M 0.02% 740
2020
Q1
$55.9M Sell
965,940
-159,043
-14% -$9.2M 0.02% 720
2019
Q4
$60.7M Buy
1,124,983
+161,148
+17% +$8.69M 0.02% 900
2019
Q3
$50.4M Buy
963,835
+83,211
+9% +$4.35M 0.01% 981
2019
Q2
$42.5M Buy
880,624
+337,422
+62% +$16.3M 0.01% 1109
2019
Q1
$27.4M Sell
543,202
-253,171
-32% -$12.8M 0.01% 1400
2018
Q4
$47.2M Sell
796,373
-233,202
-23% -$13.8M 0.02% 991
2018
Q3
$67.8M Sell
1,029,575
-35,568
-3% -$2.34M 0.02% 910
2018
Q2
$53.8M Buy
1,065,143
+150,140
+16% +$7.58M 0.01% 1040
2018
Q1
$48.2M Buy
915,003
+129,691
+17% +$6.83M 0.01% 1081
2017
Q4
$36.5M Buy
785,312
+577,036
+277% +$26.8M 0.01% 1242
2017
Q3
$8.42M Buy
208,276
+36,848
+21% +$1.49M ﹤0.01% 2069
2017
Q2
$5.81M Buy
171,428
+40,453
+31% +$1.37M ﹤0.01% 2198
2017
Q1
$3.8M Sell
130,975
-423,622
-76% -$12.3M ﹤0.01% 2352
2016
Q4
$18.2M Sell
554,597
-280,851
-34% -$9.22M 0.01% 1532
2016
Q3
$26.3M Buy
835,448
+44,336
+6% +$1.4M 0.01% 1333
2016
Q2
$22.2M Buy
791,112
+566,571
+252% +$15.9M 0.01% 1345
2016
Q1
$8.16M Sell
224,541
-70,408
-24% -$2.56M ﹤0.01% 1838
2015
Q4
$11.8M Buy
294,949
+46,126
+19% +$1.85M ﹤0.01% 1602
2015
Q3
$7.09M Sell
248,823
-119,755
-32% -$3.41M ﹤0.01% 1820
2015
Q2
$12.1M Buy
368,578
+124,472
+51% +$4.1M ﹤0.01% 1600
2015
Q1
$7.02M Sell
244,106
-15,847
-6% -$456K ﹤0.01% 1846
2014
Q4
$7.08M Sell
259,953
-90,253
-26% -$2.46M ﹤0.01% 1784
2014
Q3
$7.46M Buy
350,206
+60,899
+21% +$1.3M ﹤0.01% 1755
2014
Q2
$6.5M Buy
289,307
+12,343
+4% +$277K ﹤0.01% 1827
2014
Q1
$7M Sell
276,964
-21,710
-7% -$549K ﹤0.01% 1783
2013
Q4
$6.87M Buy
298,674
+6,985
+2% +$161K ﹤0.01% 1789
2013
Q3
$5.56M Buy
291,689
+119,495
+69% +$2.28M ﹤0.01% 1828
2013
Q2
$2.48M Buy
+172,194
New +$2.48M ﹤0.01% 2226